keyword
https://read.qxmd.com/read/38633948/navigating-treatment-dilemmas-recalcitrant-pemphigus-and-the-burden-of-multiple-comorbidities
#1
Priya Garg, Kshitiz Lakhey, Nishtha Mishra, Yash Buccha, Kirti S Deo
Pemphigus vulgaris is a chronic autoimmune disease of the skin caused by the production of autoantibodies targeting desmogleins 1 and 3 usually presenting in individuals with an average age of onset of approximately 40 years. A 35-year-old obese, diabetic woman presented with fluid-filled lesions over her body for three months along with erosions and painful ulcers in her mouth and genital area for two months. Based on clinical and histopathological studies, the patient was diagnosed as a case of pemphigus vulgaris...
March 2024: Curēus
https://read.qxmd.com/read/38631594/single-cell-sequencing-reveals-distinct-immune-cell-features-in-cutaneous-lesions-of-pemphigus-vulgaris-and-bullous-pemphigoid
#2
JOURNAL ARTICLE
Zhi Hu, Meiling Zheng, Ziyu Guo, Wenhui Zhou, Wenyu Zhou, Nan Yao, Guiying Zhang, Qianjin Lu, Ming Zhao
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are two common subtypes of autoimmune bullous disease (AIBD). The key role of circulating autoreactive immune cells contributing to skin damage of AIBD has been widely recognized. Nevertheless, the immune characteristics in cutaneous lesions remain unclear. Here, we performed single-cell RNA sequencing (scRNA-seq) and single-cell VDJ sequencing (scRNA-seq) to generate transcriptional profiles for cells and T/B cell clonetype in skin lesions of BP and PV. We found that the proportions of NK&T, macrophages/ dendritic cells, B cells, and mast cells increased in BP and PV lesions...
April 15, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38630932/effectiveness-and-safety-of-immunoadsorption-in-the-treatment-of-pemphigus-vulgaris-and-pemphigus-foliaceus
#3
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
April 17, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38617063/delayed-diagnosis-of-pemphigus-vulgaris-in-rural-nepal-due-to-healthcare-inaccessibility-and-harmful-traditional-practices-a-case-report
#4
Amisha Adhikari, Jameel Akhtar Mikrani, Samata Nepal, Ashish Rauniyar, Manish Chaudhary, Alok Atreya
Early intervention is imperative for potentially fatal dermatologic diseases such as pemphigus vulgaris. In rural Nepal, limited public awareness, home remedies, and delays in healthcare access lead to poor outcomes. Although biopsy confirms the diagnosis, experienced dermatologists can make an accurate clinical diagnosis when characteristic skin lesions are present.
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38612631/zinc-copper-and-iron-in-selected-skin-diseases
#5
REVIEW
Aleksandra Podgórska, Aleksandra Kicman, Sylwia Naliwajko, Marta Wacewicz-Muczyńska, Marek Niczyporuk
Trace elements are essential for maintaining the body's homeostasis, and their special role has been demonstrated in skin physiology. Among the most important trace elements are zinc, copper, and iron. A deficiency or excess of trace elements can be associated with an increased risk of skin diseases, so increasing their supplementation or limiting intake can be helpful in dermatological treatment. In addition, determinations of their levels in various types of biological material can be useful as additional tests in dermatological treatment...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38597739/characteristic-laryngeal-findings-in-patients-with-pemphigus-vulgaris
#6
JOURNAL ARTICLE
Makoto Hosoya, Shuta Tomisato, Nobuharu Matsumoto, Haruna Yabe, Takuji Takaoka, Hiroyuki Ozawa, Takeyuki Kono
OBJECTIVE: Pemphigus Vulgaris (PV) is a rare autoimmune disease that could cause laryngeal lesions; however, only a few studies have described the localization of the laryngeal lesions associated with this disease owing to its rarity. Therefore, this study aimed to determine the localization of laryngeal lesions in patients with PV. METHODS: Fourteen patients with PV accompanied by laryngeal or pharyngeal lesions, who underwent flexible laryngeal endoscopy performed by laryngologists, were examined retrospectively...
April 10, 2024: Laryngoscope
https://read.qxmd.com/read/38595008/clinical-and-immunological-predictors-of-post-rituximab-paradoxical-pemphigus-flare-a-prospective-cohort-study
#7
JOURNAL ARTICLE
Vishal Gupta, Rhea Ahuja, Tekumalla Sindhuja, Shafaque Imran, Ganesh Kumar Viswanathan, Manoj Kumar Tembhre, Shivam Pandey, Sujay Khandpur
Background Paradoxical flare of pemphigus following rituximab infusion has been reported previously, however, its incidence or risk factors have not been studied in detail. Objectives To evaluate the clinical and immunological predictors associated with post-rituximab paradoxical pemphigus flare. Materials and Methods This was a prospective cohort study including adult patients with pemphigus vulgaris or foliaceus who were treated with rituximab. Patients were administered 1000 mg of intravenous rituximab on days 0 and 14 (Rheumatoid arthritis (RA) protocol), with or without oral prednisolone and/or conventional immunosuppressive agents...
March 7, 2024: Indian Journal of Dermatology, Venereology and Leprology
https://read.qxmd.com/read/38591288/concordance-of-clinical-histopathologic-and-direct-immunofluorescence-findings-in-patients-with-intraepidermal-immunobullous-disorders
#8
JOURNAL ARTICLE
Erum Ashraf, Faryal Shareef
OBJECTIVE: To determine the concordance among clinical, histopathological and immunofluorescence as diagnostic methods for intraepidermal immunobullous disorders. METHODS: The prospective cross-sectional study was conducted at the Institute of Skin Diseases, Karachi, from December 2020 to December 2022, and comprised adult patients of either gender presenting with complaints of bullae, vesicles, pustules and crusts on the skin or mucous membrane. Diagnostic findings of each patient as obtained by clinical assessment, microscopy and direct immunofluorescence were compared...
March 2024: JPMA. the Journal of the Pakistan Medical Association
https://read.qxmd.com/read/38577061/a-case-of-iga-pemphigus-with-acantholysis-in-oral-mucosal-lesions
#9
Ayumi Yamanishi, Noriko Ono, Asako Tsunoda, Yasuhiko Asahina, Takayuki Fusumae, Jun Yamagami, Noriyasu Sakai, Norito Ishii, Masayuki Amagai, Hayato Takahashi
IgA pemphigus is an autoimmune bullous disease caused by anti-keratinocyte cell surface IgA autoantibodies. Mucous membrane involvement is rare in IgA pemphigus. We report a case of IgA pemphigus with oral mucosal lesions, in which acantholysis was pathologically confirmed. A 31-year-old woman presented with skin erythema with small pustules and oral mucosal erosions. Histopathological examination of the erosions on her oral mucosa and papules on her back revealed acantholysis and intraepidermal infiltration of neutrophils...
April 2024: Skin Health Dis
https://read.qxmd.com/read/38576992/paraneoplastic-pemphigus-in-a-patient-with-t-cell-lymphoma-a-case-report
#10
Yohannis Derbew Molla, Isak Omer Answar, Biruk Mulat Worku, Amanuel Kassa Tadesse, Elias Manaye Tefera, Bewketu Abebe Alemu, Gebrehiwot Lema Legese, Samuel Addisu Abera
INTRODUCTION AND IMPORTANCE: Paraneoplastic pemphigus (PNP) is an uncommon autoimmune mucocutaneous disease characterized by severe stomatitis, polymorphous skin eruptions, and the presence of underlying neoplasms. Unique histopathological features include suprabasal acantholysis and clefts with scattered necrotic keratinocytes. CASE PRESENTATION: A 27-year-old female patient presented with a 3-month history of a painless swelling, approximately the size of a pea, on the left lateral aspect of her neck and axillary area...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38569810/pemphigus-vulgaris
#11
JOURNAL ARTICLE
Nika Kianfar, Maryam Daneshpazhooh, Julia S Lehman
No abstract text is available yet for this article.
April 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38537431/maintenance-treatment-of-pemphigus-with-rituximab-in-real-life-a-single-center-study-of-50-patients
#12
JOURNAL ARTICLE
A Louchez, T El Aarbaoui, A Weill, O Gaudin, L Jelti, T Belmondo, P Wolkenstein, S Ingen-Housz-Oro
BACKGROUND: Following the RITUX 3 therapeutic trial, the French national diagnosis and care protocol (NDCP) for the treatment of pemphigus was updated in 2018. The updated protocol recommends initial treatment with rituximab (RTX) followed by maintenance therapy at 12 and 18 months, and potentially at 6 months where there are risk factors for early relapse. We evaluated these recommendations regarding the management of our own patients. PATIENTS AND METHODS: Our single-center retrospective study included all patients with pemphigus diagnosed between 01/2015 and 10/2020 and receiving at least one initial infusion of RTX...
March 25, 2024: Annales de Dermatologie et de Vénéréologie
https://read.qxmd.com/read/38534263/claudin-4-upregulation-in-acantholytic-and-autoimmune-mediated-bullous-disorders
#13
JOURNAL ARTICLE
Chau M Bui, Huy G Vuong, Minh-Khang Le, Kristin J Rybski, Hatice B Zengin, Haiming Tang, Bruce R Smoller
Claudin-4 is a key component of tight junctions, which play an important role in the formation of the epidermal barrier by forming a circumferential network in the granular layer that serves as a gatekeeper of the paracellular pathway. The aim of this study is to illustrate claudin-4 immunohistochemical staining patterns of different blistering disorders. We collected 35 cases, including two Hailey-Hailey disease, one Darier disease, three Grover disease, one acantholytic acanthoma, two warty dyskeratoma, 11 pemphigus vulgaris (PV) including six mucosal PV, and two pemphigus foliaceus...
December 21, 2023: Dermatopathology (Basel, Switzerland)
https://read.qxmd.com/read/38532568/alterations-of-circulating-free-fatty-acids-in-patients-with-pemphigus-vulgaris
#14
JOURNAL ARTICLE
Roberto Maglie, Simone Baldi, Giulia Nannini, Leandro Di Gloria, Marco Pallecchi, Gianluca Bartolucci, Matteo Ramazzotti, Elena Niccolai, Maria Efenesia Baffa, Biagioni Camilla, Farzan Solimani, Emiliano Antiga, Amedeo Amedei
Free fatty acids (FFA) have gained research interest owing to their functions in both local and systemic immune regulation. Changes in the serum levels of anti-inflammatory short chain fatty acids (SCFA), primarily derived from the gut microbiota, and pro-inflammatory medium (MCFA) and long (LCFA) chain fatty acids, derived from either the gut microbiota or the diet, have been associated with autoimmunity. Circulating FFA were retrospectively analysed by a gas chromatography-mass spectrometry method in the serum of 18 patients with pemphigus vulgaris (PV) at the baseline and 6 months (n = 10) after immunosuppressive treatments, and 18 healthy controls (HC)...
March 2024: Experimental Dermatology
https://read.qxmd.com/read/38524019/the-prevalence-of-clinically-undiagnosed-depression-in-patients-with-autoimmune-bullous-diseases-seen-at-inkosi-albert-luthuli-central-hospital-durban-south-africa
#15
JOURNAL ARTICLE
Nkosiyenzile Cele, Josiah T Masuka, Khumo Duze, Anisa Mosam
Background Chronic autoimmune bullous diseases have been associated with major depression in previous studies. This has been attributed to inflammatory cytokines, chronic pain, and the chronicity and debilitating nature of the disease. As no similar studies have been conducted in our setting, we aimed to determine the prevalence and severity of clinically undiagnosed depression in patients with autoimmune bullous diseases. Methodology We performed a cross-sectional study among outpatients managed in a bullous disease clinic at Inkosi Albert Luthuli Central Hospital, a quaternary provincial hospital in Durban, South Africa...
February 2024: Curēus
https://read.qxmd.com/read/38505433/beyond-the-surface-a-clinical-insight-into-a-60-year-old-male-with-pemphigus-vulgaris
#16
Miis Akel, Maggie Wright, Bialo Aladum, Sergio Hernandez Borges
Pemphigus vulgaris, a rare and life-threatening autoimmune disorder, presents with painful skin and mucosal lesions, leading to blistering sores attributed to acantholysis. This study delves into the clinical manifestations, risk factors, and diagnostic intricacies associated with pemphigus vulgaris, with a focus on a representative case highlighting the challenges in its recognition and management. We explore the case of a 60-year-old male with pemphigus vulgaris, whose initial presentation involved yellow-crusting lesions on the scalp progressing to non-pruritic lesions on the chest, neck, and inguinal areas...
February 2024: Curēus
https://read.qxmd.com/read/38504438/beyond-the-skin-b-cells-in-pemphigus-vulgaris-tolerance-and-treatment
#17
JOURNAL ARTICLE
Anne-Lise Strandmoe, Jeroen Bremer, Gilles F H Diercks, Antoni Gostyński, Emanuele Ammatuna, Hendri H Pas, Marjan Wouthuyzen-Bakker, Gerwin A Huls, Peter Heeringa, Jon D Laman, Barbara Horváth
Pemphigus vulgaris is a rare autoimmune bullous disease characterized by blistering of the skin and mucosa owing to the presence of autoantibodies against the desmosome proteins desmoglein 3 and occasionally in conjunction with desmoglein 1. Fundamental research into the pathogenesis of PV has revolutionized its treatment and outcome with rituximab, a B-cell-depleting therapy. The critical contribution of B cells to the pathogenesis of pemphigus is well accepted. However, the exact pathomechanism, mechanisms of onset, disease course, and relapse remain unclear...
March 20, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38493933/efficacy-and-safety-of-rilzabrutinib-in-pemphigus-pegasus-phase-3-randomized-study
#18
JOURNAL ARTICLE
Dedee F Murrell, Frédéric Caux, Aikaterini Patsatsi, Owen Hagino, Lidia Rudnicka, Snejina Vassileva, Soner Uzun, Jenny Ye, Karl Yen, Puneet Arora, Steven G Gourlay, Pascal Joly, Victoria P Werth
TRIAL DESIGN: Pemphigus is a rare, but life-threatening autoimmune disease requiring long-term treatment that minimizes corticosteroid (CS) exposure while providing consistent disease control. The phase 2 pemphigus study of oral, reversible, covalent Bruton tyrosine kinase (BTK) inhibitor rilzabrutinib demonstrated rapid and sustained efficacy with well-tolerated safety. METHODS: Adults (18-80 y) were randomized 1:1 to rilzabrutinib 400 mg (n=65) or placebo (n=66) twice daily (with CS ≤0...
March 15, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38490369/diagnostic-utility-of-gingival-biopsy-for-pemphigus-vulgaris-and-mucosa-membrane-pemphigoid-a-10-year-cohort-study
#19
JOURNAL ARTICLE
Junjiang Liu, Can Hu, Jing He, Jingtian Mu, Shimeng Wang, Qi Han, Jia Li, Mei Lin, Qinghong Gao, Fanglong Wu, Hongmei Zhou
No abstract text is available yet for this article.
March 13, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38487393/regenerative-potential-of-platelet-concentrates-in-chronic-oral-mucosal-lesions
#20
JOURNAL ARTICLE
Abdel-Hameed Hijazi, Faez Saleh Al-Hamed, Faleh Tamimi, Sadeq A Al-Maweri, Nader Hamdan, David J Psutka, Peter Ta, Hagen Klieb
Chronic oral mucosal diseases (COMDs) represent a significant challenge for clinicians and patients. They are commonly associated with chronic pain and negative effects on healing and patient's quality of life. Regenerative medicine including the use of biological autologous blood-derived substances (e.g., platelet concentrates [PCs]), has been reported to improve healing and reduce pain in orthopedic and maxillofacial surgeries as well as chronic oral mucosal diseases. In this review, we aim to describe the different types of PCs and their applications in the management of COMDs such as lichen planus, mucositis, pemphigus vulgaris, mucous membrane pemphigoid, and plasma cell mucositis, in terms of healing potential, pain control, and quality of life...
2024: Journal of Oral Biology and Craniofacial Research
keyword
keyword
40299
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.